<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01657032</url>
  </required_header>
  <id_info>
    <org_study_id>KB2010</org_study_id>
    <nct_id>NCT01657032</nct_id>
  </id_info>
  <brief_title>Efficacy of Lactobacillus GG With Diosmectite in Treatment Children With Acute Gastroenteritis</brief_title>
  <official_title>Efficacy of Lactobacillus GG With Diosmectite in Treatment Children With Acute Gastroenteritis: A Double Blind Randomized, Placebo- Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Treatment diarrhea with Lactobacillus GG or smectite has proven efficacy. A randomized,
      double blind, placebo-control trial was performed to assess the effectiveness of both LGG and
      smectite in management of children with acute gastroenteritis (AGE).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ESPGHAN agreed to use probiotics, with proven efficacy, and smectite in treatment of AGE as
      an adjunct to standard rehydration therapy. Among probiotics Lactobacillus GG were found to
      be beneficial in meta-analyses. Treatment with LGG was associated with a significant
      reduction in diarrhea duration.

      A recent review systematically evaluated the efficacy of smectite in treating acute
      infections diarrhea in infants and children.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of Diarrhea</measure>
    <time_frame>counted in days during 7days</time_frame>
    <description>The primary outcome measure is duration of diarrhea (counted in days; from the first loose stool to the last one; end of diarrhea defined as last loose stool or at least 12hours without stool).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of Loose Stools,</measure>
    <time_frame>number of loose stools during 7 days</time_frame>
    <description>number of loose stools during 7 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consistency of Stools</measure>
    <time_frame>day 4-th</time_frame>
    <description>consistency of stools using Bristool Stool Scale Form on day 4-th. (The Bristol stool scale form is a medical aid designed to classify the form of human faeces into seven categories.
Type 1 Separate hard lumps, like nuts (hard to pass) Type 2 Sausage-shaped but lumpy Type 3 Like a sausage but with cracks on the surface Type 4 Like a sausage or snake, smooth and soft Type 5 Soft blobs with clear-cut edges Type 6 Fluffy pieces with ragged edges, a mushy stool Type 7 Watery, no solid pieces. Entirely liquid Types 1-2 indicate constipation, with 3 and 4 being the ideal stools (especially the latter), as they are easy to defecate while not containing any excess liquid, and 5, 6 and 7 tending towards diarrhoea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for Antibiotic Therapy,</measure>
    <time_frame>yes/no, for 7days</time_frame>
    <description>need for antibiotic therapy because of diarrhea</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vomiting</measure>
    <time_frame>yes/no, for 7days</time_frame>
    <description>If the child vomiting after randomization (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vomiting</measure>
    <time_frame>how many times for 7days</time_frame>
    <description>How many times the child was vomiting (during the study)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diarrhea Recurrence</measure>
    <time_frame>7 days</time_frame>
    <description>If the was a diarrhea recurrence during 7days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance of Products</measure>
    <time_frame>7days</time_frame>
    <description>tolerance of products (whether the child took medicaments),</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for Hospitalization</measure>
    <time_frame>7 days</time_frame>
    <description>If the child need to hospitalized</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for Intravenous Therapy</measure>
    <time_frame>yes/no, for 7days</time_frame>
    <description>need for intravenous rehydration therapy (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Intravenous Therapy</measure>
    <time_frame>7days</time_frame>
    <description>need for intravenous rehydration therapy (how long if needed)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Diarrhea</condition>
  <arm_group>
    <arm_group_label>Lactobacillus GG and Smectite</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lactobacillus GG and Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Smectite</intervention_name>
    <description>Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.</description>
    <arm_group_label>Lactobacillus GG and Smectite</arm_group_label>
    <other_name>Smecta</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.</description>
    <arm_group_label>Lactobacillus GG and Placebo</arm_group_label>
    <other_name>glucose</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus GG</intervention_name>
    <description>All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
    <arm_group_label>Lactobacillus GG and Smectite</arm_group_label>
    <arm_group_label>Lactobacillus GG and Placebo</arm_group_label>
    <other_name>Dicoflor 30</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children &lt; 5 years old

          -  diarrhea (defined as the passage of 3 or more loose or watery stools per day) for &gt; 1
             day but &lt; 5 days

          -  inform consent sing

        Exclusion Criteria:

          -  diarrhea &lt; 1 or &gt; 5 days,

          -  a recent history of diarrhea indicated either by parents/guardian or hospital case
             notes,

          -  underlying chronic gastrointestinal disease,

          -  undernutrition (weight/height ratio below the 5th percentile),

          -  systematic infection,

          -  immune defects or immunosuppressive treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Paediatrics, The Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <zip>01-183</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Guarino A, Albano F, Ashkenazi S, Gendrel D, Hoekstra JH, Shamir R, Szajewska H; ESPGHAN/ESPID Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe Expert Working Group. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: executive summary. J Pediatr Gastroenterol Nutr. 2008 May;46(5):619-21. doi: 10.1097/MPG.0b013e31816e219e.</citation>
    <PMID>18493225</PMID>
  </reference>
  <reference>
    <citation>Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol. 1998 Feb 17;39(3):237-8.</citation>
    <PMID>9553803</PMID>
  </reference>
  <reference>
    <citation>Szajewska H, Skórka A, Ruszczyński M, Gieruszczak-Białek D. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther. 2007 Apr 15;25(8):871-81. Review.</citation>
    <PMID>17402990</PMID>
  </reference>
  <reference>
    <citation>Szajewska H, Dziechciarz P, Mrukowicz J. Meta-analysis: Smectite in the treatment of acute infectious diarrhoea in children. Aliment Pharmacol Ther. 2006 Jan 15;23(2):217-27.</citation>
    <PMID>16393300</PMID>
  </reference>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2012</study_first_submitted>
  <study_first_submitted_qc>August 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2012</study_first_posted>
  <results_first_submitted>November 20, 2013</results_first_submitted>
  <results_first_submitted_qc>February 14, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 1, 2014</results_first_posted>
  <last_update_submitted>February 14, 2014</last_update_submitted>
  <last_update_submitted_qc>February 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diarrhea</keyword>
  <keyword>probiotics</keyword>
  <keyword>diosmectite</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Gastroenteritis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Lactobacillus GG and Smectite</title>
          <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
        </group>
        <group group_id="P2">
          <title>Lactobacillus GG and Placebo</title>
          <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Lactobacillus GG and Smectite</title>
          <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
        </group>
        <group group_id="B2">
          <title>Lactobacillus GG and Placebo</title>
          <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="44"/>
            <count group_id="B2" value="44"/>
            <count group_id="B3" value="88"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17.5" lower_limit="10.0" upper_limit="22.5"/>
                    <measurement group_id="B2" value="18" lower_limit="11" upper_limit="30"/>
                    <measurement group_id="B3" value="18" lower_limit="10" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Poland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Duration of Diarrhea</title>
        <description>The primary outcome measure is duration of diarrhea (counted in days; from the first loose stool to the last one; end of diarrhea defined as last loose stool or at least 12hours without stool).</description>
        <time_frame>counted in days during 7days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactobacillus GG and Smectite</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
          <group group_id="O2">
            <title>Lactobacillus GG and Placebo</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Diarrhea</title>
          <description>The primary outcome measure is duration of diarrhea (counted in days; from the first loose stool to the last one; end of diarrhea defined as last loose stool or at least 12hours without stool).</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The differences between the study groups were considered significant when the P value was &lt;0.05.</non_inferiority_desc>
            <p_value>0.43</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Frequency of Loose Stools,</title>
        <description>number of loose stools during 7 days</description>
        <time_frame>number of loose stools during 7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactobacillus GG and Smectite</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
          <group group_id="O2">
            <title>Lactobacillus GG and Placebo</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
        </group_list>
        <measure>
          <title>Frequency of Loose Stools,</title>
          <description>number of loose stools during 7 days</description>
          <units>number of loose stools during 7days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.5" lower_limit="5" upper_limit="21"/>
                    <measurement group_id="O2" value="10" lower_limit="5" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Consistency of Stools</title>
        <description>consistency of stools using Bristool Stool Scale Form on day 4-th. (The Bristol stool scale form is a medical aid designed to classify the form of human faeces into seven categories.
Type 1 Separate hard lumps, like nuts (hard to pass) Type 2 Sausage-shaped but lumpy Type 3 Like a sausage but with cracks on the surface Type 4 Like a sausage or snake, smooth and soft Type 5 Soft blobs with clear-cut edges Type 6 Fluffy pieces with ragged edges, a mushy stool Type 7 Watery, no solid pieces. Entirely liquid Types 1–2 indicate constipation, with 3 and 4 being the ideal stools (especially the latter), as they are easy to defecate while not containing any excess liquid, and 5, 6 and 7 tending towards diarrhoea.</description>
        <time_frame>day 4-th</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactobacillus GG and Smectite</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
          <group group_id="O2">
            <title>Lactobacillus GG and Placebo</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
        </group_list>
        <measure>
          <title>Consistency of Stools</title>
          <description>consistency of stools using Bristool Stool Scale Form on day 4-th. (The Bristol stool scale form is a medical aid designed to classify the form of human faeces into seven categories.
Type 1 Separate hard lumps, like nuts (hard to pass) Type 2 Sausage-shaped but lumpy Type 3 Like a sausage but with cracks on the surface Type 4 Like a sausage or snake, smooth and soft Type 5 Soft blobs with clear-cut edges Type 6 Fluffy pieces with ragged edges, a mushy stool Type 7 Watery, no solid pieces. Entirely liquid Types 1–2 indicate constipation, with 3 and 4 being the ideal stools (especially the latter), as they are easy to defecate while not containing any excess liquid, and 5, 6 and 7 tending towards diarrhoea.</description>
          <units>Units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="3" upper_limit="6"/>
                    <measurement group_id="O2" value="4" lower_limit="0" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Need for Antibiotic Therapy,</title>
        <description>need for antibiotic therapy because of diarrhea</description>
        <time_frame>yes/no, for 7days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactobacillus GG and Smectite</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
          <group group_id="O2">
            <title>Lactobacillus GG and Placebo</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
        </group_list>
        <measure>
          <title>Need for Antibiotic Therapy,</title>
          <description>need for antibiotic therapy because of diarrhea</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vomiting</title>
        <description>If the child vomiting after randomization (yes/no)</description>
        <time_frame>yes/no, for 7days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactobacillus GG and Smectite</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
          <group group_id="O2">
            <title>Lactobacillus GG and Placebo</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
        </group_list>
        <measure>
          <title>Vomiting</title>
          <description>If the child vomiting after randomization (yes/no)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vomiting</title>
        <description>How many times the child was vomiting (during the study)</description>
        <time_frame>how many times for 7days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactobacillus GG and Smectite</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
          <group group_id="O2">
            <title>Lactobacillus GG and Placebo</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
        </group_list>
        <measure>
          <title>Vomiting</title>
          <description>How many times the child was vomiting (during the study)</description>
          <units>vomiting episodes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diarrhea Recurrence</title>
        <description>If the was a diarrhea recurrence during 7days</description>
        <time_frame>7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactobacillus GG and Smectite</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
          <group group_id="O2">
            <title>Lactobacillus GG and Placebo</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
        </group_list>
        <measure>
          <title>Diarrhea Recurrence</title>
          <description>If the was a diarrhea recurrence during 7days</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tolerance of Products</title>
        <description>tolerance of products (whether the child took medicaments),</description>
        <time_frame>7days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactobacillus GG and Smectite</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
          <group group_id="O2">
            <title>Lactobacillus GG and Placebo</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
        </group_list>
        <measure>
          <title>Tolerance of Products</title>
          <description>tolerance of products (whether the child took medicaments),</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Need for Hospitalization</title>
        <description>If the child need to hospitalized</description>
        <time_frame>7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactobacillus GG and Smectite</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
          <group group_id="O2">
            <title>Lactobacillus GG and Placebo</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
        </group_list>
        <measure>
          <title>Need for Hospitalization</title>
          <description>If the child need to hospitalized</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Need for Intravenous Therapy</title>
        <description>need for intravenous rehydration therapy (yes/no)</description>
        <time_frame>yes/no, for 7days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactobacillus GG and Smectite</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
          <group group_id="O2">
            <title>Lactobacillus GG and Placebo</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
        </group_list>
        <measure>
          <title>Need for Intravenous Therapy</title>
          <description>need for intravenous rehydration therapy (yes/no)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Intravenous Therapy</title>
        <description>need for intravenous rehydration therapy (how long if needed)</description>
        <time_frame>7days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactobacillus GG and Smectite</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
          <group group_id="O2">
            <title>Lactobacillus GG and Placebo</title>
            <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Intravenous Therapy</title>
          <description>need for intravenous rehydration therapy (how long if needed)</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>7days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Lactobacillus GG and Smectite</title>
          <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
smectite, dose 3 g, once daily orally until diarrhea stopped
Smectite: Eligible children received smectite (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
        </group>
        <group group_id="E2">
          <title>Lactobacillus GG and Placebo</title>
          <description>Children received:
LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days and
placebo (glucose), dose 3 g, once daily orally until diarrhea stopped
Placebo: Eligible children received placebo: glucose (3g) once a day till diarrhea stop with LGG (ATCC 53103) at a daily dosage of 6×10 9 colony forming units (CFU) in one dose for 7 days.
Lactobacillus GG: All children received LGG (ATCC 53103), dose 6×10 9 colony forming units (CFU), once a day for 7 days with placebo or smectite</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>A potential limitation of our study is the lack of perfect blinding. Patients received smectite or placebo in identical packages from the hospital pharmacy. After being dissolved in water, they were of different colors.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Hanna Szajewska, Malgorzata Pieścik-Lech</name_or_title>
      <organization>The Medical University of Warsaw</organization>
      <phone>+48-22-45-23-309</phone>
      <email>hania@ipgate.pl</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

